Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
RHOXF1
|
ENSG00000101883.4 | Rhox homeobox family member 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
RHOXF1 | hg19_v2_chrX_-_119249819_119249847 | 0.43 | 1.3e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_-_3479086 | 4.96 |
ENST00000587847.1
|
C19orf77
|
chromosome 19 open reading frame 77 |
chr3_-_179691866 | 3.56 |
ENST00000464614.1
ENST00000476138.1 ENST00000463761.1 |
PEX5L
|
peroxisomal biogenesis factor 5-like |
chr3_-_19975665 | 3.41 |
ENST00000295824.9
ENST00000389256.4 |
EFHB
|
EF-hand domain family, member B |
chr7_+_117864708 | 3.19 |
ENST00000357099.4
ENST00000265224.4 ENST00000486422.1 ENST00000417525.1 |
ANKRD7
|
ankyrin repeat domain 7 |
chr10_-_49482907 | 3.14 |
ENST00000374201.3
ENST00000407470.4 |
FRMPD2
|
FERM and PDZ domain containing 2 |
chr10_-_75401500 | 3.12 |
ENST00000359322.4
|
MYOZ1
|
myozenin 1 |
chr8_+_35649365 | 3.07 |
ENST00000437887.1
|
AC012215.1
|
Uncharacterized protein |
chr10_-_105992059 | 3.06 |
ENST00000369720.1
ENST00000369719.1 ENST00000357060.3 ENST00000428666.1 ENST00000278064.2 |
WDR96
|
WD repeat domain 96 |
chr17_+_68100989 | 2.95 |
ENST00000585558.1
ENST00000392670.1 |
KCNJ16
|
potassium inwardly-rectifying channel, subfamily J, member 16 |
chr11_+_71903169 | 2.89 |
ENST00000393676.3
|
FOLR1
|
folate receptor 1 (adult) |
chr3_+_63638339 | 2.84 |
ENST00000343837.3
ENST00000469440.1 |
SNTN
|
sentan, cilia apical structure protein |
chr16_+_80574854 | 2.77 |
ENST00000305904.6
ENST00000568035.1 |
DYNLRB2
|
dynein, light chain, roadblock-type 2 |
chr17_+_65027509 | 2.74 |
ENST00000375684.1
|
AC005544.1
|
Uncharacterized protein |
chr11_-_119993979 | 2.73 |
ENST00000524816.3
ENST00000525327.1 |
TRIM29
|
tripartite motif containing 29 |
chr18_-_24443151 | 2.65 |
ENST00000440832.3
|
AQP4
|
aquaporin 4 |
chr8_-_38006272 | 2.64 |
ENST00000522050.1
|
STAR
|
steroidogenic acute regulatory protein |
chr8_-_28347737 | 2.62 |
ENST00000517673.1
ENST00000518734.1 ENST00000346498.2 ENST00000380254.2 |
FBXO16
|
F-box protein 16 |
chr17_+_68101117 | 2.56 |
ENST00000587698.1
ENST00000587892.1 |
KCNJ16
|
potassium inwardly-rectifying channel, subfamily J, member 16 |
chr7_+_117864815 | 2.52 |
ENST00000433239.1
|
ANKRD7
|
ankyrin repeat domain 7 |
chrX_-_139866723 | 2.52 |
ENST00000370532.2
|
CDR1
|
cerebellar degeneration-related protein 1, 34kDa |
chr11_-_108338218 | 2.51 |
ENST00000525729.1
ENST00000393084.1 |
C11orf65
|
chromosome 11 open reading frame 65 |
chr1_-_205326022 | 2.48 |
ENST00000367155.3
|
KLHDC8A
|
kelch domain containing 8A |
chr9_+_34458771 | 2.48 |
ENST00000437363.1
ENST00000242317.4 |
DNAI1
|
dynein, axonemal, intermediate chain 1 |
chr1_+_169079823 | 2.46 |
ENST00000367813.3
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr8_+_54764346 | 2.44 |
ENST00000297313.3
ENST00000344277.6 |
RGS20
|
regulator of G-protein signaling 20 |
chrX_-_71526999 | 2.43 |
ENST00000453707.2
ENST00000373619.3 |
CITED1
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 |
chr10_-_99771079 | 2.38 |
ENST00000309155.3
|
CRTAC1
|
cartilage acidic protein 1 |
chr11_+_6260298 | 2.37 |
ENST00000379936.2
|
CNGA4
|
cyclic nucleotide gated channel alpha 4 |
chr1_-_205326161 | 2.37 |
ENST00000367156.3
ENST00000606887.1 ENST00000607173.1 |
KLHDC8A
|
kelch domain containing 8A |
chr13_-_103019744 | 2.24 |
ENST00000437115.2
|
FGF14-IT1
|
FGF14 intronic transcript 1 (non-protein coding) |
chrX_-_10851762 | 2.24 |
ENST00000380785.1
ENST00000380787.1 |
MID1
|
midline 1 (Opitz/BBB syndrome) |
chr3_-_193272588 | 2.23 |
ENST00000295548.3
|
ATP13A4
|
ATPase type 13A4 |
chr2_-_2334888 | 2.15 |
ENST00000428368.2
ENST00000399161.2 |
MYT1L
|
myelin transcription factor 1-like |
chr1_-_153085984 | 2.11 |
ENST00000468739.1
|
SPRR2F
|
small proline-rich protein 2F |
chr15_-_83316254 | 2.09 |
ENST00000567678.1
ENST00000450751.2 |
CPEB1
|
cytoplasmic polyadenylation element binding protein 1 |
chr1_-_205325850 | 2.08 |
ENST00000537168.1
|
KLHDC8A
|
kelch domain containing 8A |
chr3_-_179692042 | 2.07 |
ENST00000468741.1
|
PEX5L
|
peroxisomal biogenesis factor 5-like |
chr19_+_54495542 | 2.06 |
ENST00000252729.2
ENST00000352529.1 |
CACNG6
|
calcium channel, voltage-dependent, gamma subunit 6 |
chr16_+_6069072 | 2.05 |
ENST00000547605.1
ENST00000550418.1 ENST00000553186.1 |
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
chr6_-_11779840 | 2.02 |
ENST00000506810.1
|
ADTRP
|
androgen-dependent TFPI-regulating protein |
chrX_+_103028638 | 2.00 |
ENST00000434483.1
|
PLP1
|
proteolipid protein 1 |
chr14_+_106744269 | 1.98 |
ENST00000458560.1
ENST00000415154.1 |
LINC00226
|
long intergenic non-protein coding RNA 226 |
chr1_-_213020991 | 1.97 |
ENST00000332912.3
|
C1orf227
|
chromosome 1 open reading frame 227 |
chr9_+_34458851 | 1.95 |
ENST00000545019.1
|
DNAI1
|
dynein, axonemal, intermediate chain 1 |
chr19_-_38878632 | 1.95 |
ENST00000586599.1
ENST00000334928.6 ENST00000587676.1 |
GGN
|
gametogenetin |
chr20_+_44098385 | 1.94 |
ENST00000217425.5
ENST00000339946.3 |
WFDC2
|
WAP four-disulfide core domain 2 |
chr1_+_163038565 | 1.94 |
ENST00000421743.2
|
RGS4
|
regulator of G-protein signaling 4 |
chr14_+_94640633 | 1.94 |
ENST00000304338.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
chr8_-_38006636 | 1.94 |
ENST00000521236.1
|
STAR
|
steroidogenic acute regulatory protein |
chr3_-_193272874 | 1.93 |
ENST00000342695.4
|
ATP13A4
|
ATPase type 13A4 |
chr2_-_56150910 | 1.92 |
ENST00000424836.2
ENST00000438672.1 ENST00000440439.1 ENST00000429909.1 ENST00000424207.1 ENST00000452337.1 ENST00000355426.3 ENST00000439193.1 ENST00000421664.1 |
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1 |
chr4_+_110769258 | 1.92 |
ENST00000594814.1
|
LRIT3
|
leucine-rich repeat, immunoglobulin-like and transmembrane domains 3 |
chr15_+_42696954 | 1.91 |
ENST00000337571.4
ENST00000569136.1 |
CAPN3
|
calpain 3, (p94) |
chr15_+_42696992 | 1.91 |
ENST00000561817.1
|
CAPN3
|
calpain 3, (p94) |
chr9_+_127615733 | 1.88 |
ENST00000373574.1
|
WDR38
|
WD repeat domain 38 |
chr20_+_44098346 | 1.88 |
ENST00000372676.3
|
WFDC2
|
WAP four-disulfide core domain 2 |
chr14_+_93389425 | 1.85 |
ENST00000216492.5
ENST00000334654.4 |
CHGA
|
chromogranin A (parathyroid secretory protein 1) |
chr13_-_103053946 | 1.84 |
ENST00000376131.4
|
FGF14
|
fibroblast growth factor 14 |
chr14_+_67999999 | 1.82 |
ENST00000329153.5
|
PLEKHH1
|
pleckstrin homology domain containing, family H (with MyTH4 domain) member 1 |
chr5_+_140734570 | 1.81 |
ENST00000571252.1
|
PCDHGA4
|
protocadherin gamma subfamily A, 4 |
chr3_+_132757215 | 1.80 |
ENST00000321871.6
ENST00000393130.3 ENST00000514894.1 ENST00000512662.1 |
TMEM108
|
transmembrane protein 108 |
chr15_-_33360342 | 1.79 |
ENST00000558197.1
|
FMN1
|
formin 1 |
chr15_+_54901540 | 1.78 |
ENST00000539562.2
|
UNC13C
|
unc-13 homolog C (C. elegans) |
chrX_+_72064876 | 1.77 |
ENST00000373532.3
ENST00000333826.5 |
DMRTC1B
|
DMRT-like family C1B |
chr11_+_61522844 | 1.77 |
ENST00000265460.5
|
MYRF
|
myelin regulatory factor |
chr8_+_134029937 | 1.75 |
ENST00000518108.1
|
TG
|
thyroglobulin |
chr15_-_83315874 | 1.74 |
ENST00000569257.1
|
CPEB1
|
cytoplasmic polyadenylation element binding protein 1 |
chr2_-_56150184 | 1.73 |
ENST00000394554.1
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1 |
chr9_+_71986182 | 1.71 |
ENST00000303068.7
|
FAM189A2
|
family with sequence similarity 189, member A2 |
chr11_+_98891797 | 1.71 |
ENST00000527185.1
ENST00000528682.1 ENST00000524871.1 |
CNTN5
|
contactin 5 |
chr15_+_42697065 | 1.71 |
ENST00000565559.1
|
CAPN3
|
calpain 3, (p94) |
chr16_-_5116025 | 1.70 |
ENST00000472572.3
ENST00000315997.5 ENST00000422873.1 ENST00000350219.4 |
C16orf89
|
chromosome 16 open reading frame 89 |
chr12_-_113574028 | 1.70 |
ENST00000546530.1
ENST00000261729.5 |
RASAL1
|
RAS protein activator like 1 (GAP1 like) |
chrX_-_137793826 | 1.70 |
ENST00000315930.6
|
FGF13
|
fibroblast growth factor 13 |
chr2_+_16080659 | 1.68 |
ENST00000281043.3
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog |
chr3_-_193272741 | 1.67 |
ENST00000392443.3
|
ATP13A4
|
ATPase type 13A4 |
chr18_+_56892724 | 1.66 |
ENST00000456142.3
ENST00000530323.1 |
GRP
|
gastrin-releasing peptide |
chr16_+_58010339 | 1.65 |
ENST00000290871.5
ENST00000441824.2 |
TEPP
|
testis, prostate and placenta expressed |
chr15_+_42697018 | 1.64 |
ENST00000397204.4
|
CAPN3
|
calpain 3, (p94) |
chr9_-_95298314 | 1.64 |
ENST00000344604.5
ENST00000375540.1 |
ECM2
|
extracellular matrix protein 2, female organ and adipocyte specific |
chr1_+_156308245 | 1.64 |
ENST00000368253.2
ENST00000470342.1 ENST00000368254.1 |
TSACC
|
TSSK6 activating co-chaperone |
chr5_+_7654057 | 1.64 |
ENST00000537121.1
|
ADCY2
|
adenylate cyclase 2 (brain) |
chr3_-_98241358 | 1.61 |
ENST00000503004.1
ENST00000506575.1 ENST00000513452.1 ENST00000515620.1 |
CLDND1
|
claudin domain containing 1 |
chr9_-_112083229 | 1.61 |
ENST00000374566.3
ENST00000374557.4 |
EPB41L4B
|
erythrocyte membrane protein band 4.1 like 4B |
chr12_-_25348007 | 1.61 |
ENST00000354189.5
ENST00000545133.1 ENST00000554347.1 ENST00000395987.3 ENST00000320267.9 ENST00000395990.2 ENST00000537577.1 |
CASC1
|
cancer susceptibility candidate 1 |
chr11_-_119993734 | 1.60 |
ENST00000533302.1
|
TRIM29
|
tripartite motif containing 29 |
chr1_-_204329013 | 1.60 |
ENST00000272203.3
ENST00000414478.1 |
PLEKHA6
|
pleckstrin homology domain containing, family A member 6 |
chr17_-_74137374 | 1.60 |
ENST00000322957.6
|
FOXJ1
|
forkhead box J1 |
chr6_+_46661575 | 1.58 |
ENST00000450697.1
|
TDRD6
|
tudor domain containing 6 |
chr12_-_103310987 | 1.56 |
ENST00000307000.2
|
PAH
|
phenylalanine hydroxylase |
chr6_-_42690312 | 1.55 |
ENST00000230381.5
|
PRPH2
|
peripherin 2 (retinal degeneration, slow) |
chr7_+_94285637 | 1.55 |
ENST00000482108.1
ENST00000488574.1 |
PEG10
|
paternally expressed 10 |
chr15_+_74466744 | 1.54 |
ENST00000560862.1
ENST00000395118.1 |
ISLR
|
immunoglobulin superfamily containing leucine-rich repeat |
chr18_-_3880051 | 1.53 |
ENST00000584874.1
|
DLGAP1
|
discs, large (Drosophila) homolog-associated protein 1 |
chrX_+_72064690 | 1.53 |
ENST00000438696.1
|
DMRTC1B
|
DMRT-like family C1B |
chrX_+_18725758 | 1.53 |
ENST00000472826.1
ENST00000544635.1 ENST00000496075.2 |
PPEF1
|
protein phosphatase, EF-hand calcium binding domain 1 |
chr14_-_73997901 | 1.52 |
ENST00000557603.1
ENST00000556455.1 |
HEATR4
|
HEAT repeat containing 4 |
chr3_-_58613323 | 1.51 |
ENST00000474531.1
ENST00000465970.1 |
FAM107A
|
family with sequence similarity 107, member A |
chr2_-_135805008 | 1.51 |
ENST00000414343.1
|
MAP3K19
|
mitogen-activated protein kinase kinase kinase 19 |
chrX_+_23018058 | 1.51 |
ENST00000327968.5
|
DDX53
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 53 |
chr8_-_42360015 | 1.51 |
ENST00000522707.1
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2 |
chr15_+_34261089 | 1.51 |
ENST00000383263.5
|
CHRM5
|
cholinergic receptor, muscarinic 5 |
chr1_-_205325994 | 1.49 |
ENST00000491471.1
|
KLHDC8A
|
kelch domain containing 8A |
chr2_+_170366203 | 1.49 |
ENST00000284669.1
|
KLHL41
|
kelch-like family member 41 |
chr14_+_101299520 | 1.48 |
ENST00000455531.1
|
MEG3
|
maternally expressed 3 (non-protein coding) |
chr4_+_88754113 | 1.47 |
ENST00000560249.1
ENST00000540395.1 ENST00000511670.1 ENST00000361056.3 |
MEPE
|
matrix extracellular phosphoglycoprotein |
chr9_+_34957477 | 1.46 |
ENST00000544237.1
|
KIAA1045
|
KIAA1045 |
chr1_+_81771806 | 1.46 |
ENST00000370721.1
ENST00000370727.1 ENST00000370725.1 ENST00000370723.1 ENST00000370728.1 ENST00000370730.1 |
LPHN2
|
latrophilin 2 |
chr2_+_173792893 | 1.45 |
ENST00000535187.1
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr14_+_70346125 | 1.45 |
ENST00000361956.3
ENST00000381280.4 |
SMOC1
|
SPARC related modular calcium binding 1 |
chrX_+_114874727 | 1.45 |
ENST00000543070.1
|
PLS3
|
plastin 3 |
chr6_+_151646800 | 1.44 |
ENST00000354675.6
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chr1_-_154458520 | 1.44 |
ENST00000486773.1
|
SHE
|
Src homology 2 domain containing E |
chr6_+_72596604 | 1.43 |
ENST00000348717.5
ENST00000517960.1 ENST00000518273.1 ENST00000522291.1 ENST00000521978.1 ENST00000520567.1 ENST00000264839.7 |
RIMS1
|
regulating synaptic membrane exocytosis 1 |
chr3_-_47324008 | 1.43 |
ENST00000425853.1
|
KIF9
|
kinesin family member 9 |
chr2_-_217560248 | 1.43 |
ENST00000233813.4
|
IGFBP5
|
insulin-like growth factor binding protein 5 |
chr6_+_159290917 | 1.43 |
ENST00000367072.1
|
C6orf99
|
chromosome 6 open reading frame 99 |
chr4_-_16077741 | 1.42 |
ENST00000447510.2
ENST00000540805.1 ENST00000539194.1 |
PROM1
|
prominin 1 |
chr17_+_45908974 | 1.42 |
ENST00000269025.4
|
LRRC46
|
leucine rich repeat containing 46 |
chr11_+_61248583 | 1.42 |
ENST00000432063.2
ENST00000338608.2 |
PPP1R32
|
protein phosphatase 1, regulatory subunit 32 |
chr7_-_122339162 | 1.42 |
ENST00000340112.2
|
RNF133
|
ring finger protein 133 |
chr6_+_159291090 | 1.41 |
ENST00000367073.4
ENST00000608817.1 |
C6orf99
|
chromosome 6 open reading frame 99 |
chr10_-_124459284 | 1.41 |
ENST00000432000.1
ENST00000329446.4 |
C10orf120
|
chromosome 10 open reading frame 120 |
chr15_+_43885252 | 1.41 |
ENST00000453782.1
ENST00000300283.6 ENST00000437924.1 ENST00000450086.2 |
CKMT1B
|
creatine kinase, mitochondrial 1B |
chr16_+_76587314 | 1.41 |
ENST00000563764.1
|
RP11-58C22.1
|
Uncharacterized protein |
chr22_+_45809560 | 1.40 |
ENST00000342894.3
ENST00000538017.1 |
RIBC2
|
RIB43A domain with coiled-coils 2 |
chr12_+_13061894 | 1.39 |
ENST00000540125.1
|
GPRC5A
|
G protein-coupled receptor, family C, group 5, member A |
chr1_+_15272271 | 1.38 |
ENST00000400797.3
|
KAZN
|
kazrin, periplakin interacting protein |
chr12_-_21487829 | 1.38 |
ENST00000445053.1
ENST00000452078.1 ENST00000458504.1 ENST00000422327.1 ENST00000421294.1 |
SLCO1A2
|
solute carrier organic anion transporter family, member 1A2 |
chr19_+_45418067 | 1.37 |
ENST00000589078.1
ENST00000586638.1 |
APOC1
|
apolipoprotein C-I |
chr6_+_30856507 | 1.37 |
ENST00000513240.1
ENST00000424544.2 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
chr1_+_110993795 | 1.37 |
ENST00000271331.3
|
PROK1
|
prokineticin 1 |
chr11_+_111385497 | 1.36 |
ENST00000375618.4
ENST00000529167.1 ENST00000332814.6 |
C11orf88
|
chromosome 11 open reading frame 88 |
chrX_-_72095808 | 1.36 |
ENST00000373529.5
|
DMRTC1
|
DMRT-like family C1 |
chr12_+_119616447 | 1.36 |
ENST00000281938.2
|
HSPB8
|
heat shock 22kDa protein 8 |
chr2_-_152830479 | 1.36 |
ENST00000360283.6
|
CACNB4
|
calcium channel, voltage-dependent, beta 4 subunit |
chr1_+_111888890 | 1.36 |
ENST00000369738.4
|
PIFO
|
primary cilia formation |
chr5_+_140579162 | 1.36 |
ENST00000536699.1
ENST00000354757.3 |
PCDHB11
|
protocadherin beta 11 |
chr20_-_52645231 | 1.35 |
ENST00000448484.1
|
BCAS1
|
breast carcinoma amplified sequence 1 |
chr19_+_36027660 | 1.35 |
ENST00000585510.1
|
GAPDHS
|
glyceraldehyde-3-phosphate dehydrogenase, spermatogenic |
chr1_+_156611900 | 1.35 |
ENST00000457777.2
ENST00000424639.1 |
BCAN
|
brevican |
chrX_+_103029314 | 1.34 |
ENST00000429977.1
|
PLP1
|
proteolipid protein 1 |
chr15_-_83316087 | 1.34 |
ENST00000568757.1
|
CPEB1
|
cytoplasmic polyadenylation element binding protein 1 |
chr7_+_39125365 | 1.33 |
ENST00000559001.1
ENST00000464276.2 |
POU6F2
|
POU class 6 homeobox 2 |
chr1_+_197237352 | 1.32 |
ENST00000538660.1
ENST00000367400.3 ENST00000367399.2 |
CRB1
|
crumbs homolog 1 (Drosophila) |
chrX_+_150884539 | 1.32 |
ENST00000417321.1
|
FATE1
|
fetal and adult testis expressed 1 |
chr13_+_78109884 | 1.31 |
ENST00000377246.3
ENST00000349847.3 |
SCEL
|
sciellin |
chr14_+_94640671 | 1.31 |
ENST00000328839.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
chr18_-_53804580 | 1.31 |
ENST00000590484.1
ENST00000589293.1 ENST00000587904.1 ENST00000591974.1 |
RP11-456O19.4
|
RP11-456O19.4 |
chr8_-_101118185 | 1.31 |
ENST00000523437.1
|
RGS22
|
regulator of G-protein signaling 22 |
chr1_-_31661000 | 1.30 |
ENST00000263693.1
ENST00000398657.2 ENST00000526106.1 |
NKAIN1
|
Na+/K+ transporting ATPase interacting 1 |
chr11_+_60699222 | 1.29 |
ENST00000536409.1
|
TMEM132A
|
transmembrane protein 132A |
chr17_+_48911942 | 1.29 |
ENST00000426127.1
|
WFIKKN2
|
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 |
chr10_-_28270795 | 1.29 |
ENST00000545014.1
|
ARMC4
|
armadillo repeat containing 4 |
chr3_-_47324079 | 1.28 |
ENST00000352910.4
|
KIF9
|
kinesin family member 9 |
chr1_+_151682909 | 1.28 |
ENST00000326413.3
ENST00000442233.2 |
RIIAD1
AL589765.1
|
regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1 Uncharacterized protein; cDNA FLJ36032 fis, clone TESTI2017069 |
chr7_+_37960163 | 1.28 |
ENST00000199448.4
ENST00000559325.1 ENST00000423717.1 |
EPDR1
|
ependymin related 1 |
chrX_+_30233668 | 1.28 |
ENST00000378988.4
|
MAGEB2
|
melanoma antigen family B, 2 |
chr5_+_140235469 | 1.27 |
ENST00000506939.2
ENST00000307360.5 |
PCDHA10
|
protocadherin alpha 10 |
chr5_+_140593509 | 1.27 |
ENST00000341948.4
|
PCDHB13
|
protocadherin beta 13 |
chrX_+_152912616 | 1.27 |
ENST00000342782.3
|
DUSP9
|
dual specificity phosphatase 9 |
chr19_+_36359341 | 1.27 |
ENST00000221891.4
|
APLP1
|
amyloid beta (A4) precursor-like protein 1 |
chr11_+_33563821 | 1.27 |
ENST00000321505.4
ENST00000265654.5 ENST00000389726.3 |
KIAA1549L
|
KIAA1549-like |
chr19_-_17799008 | 1.26 |
ENST00000519716.2
|
UNC13A
|
unc-13 homolog A (C. elegans) |
chr9_-_95298254 | 1.26 |
ENST00000444490.2
|
ECM2
|
extracellular matrix protein 2, female organ and adipocyte specific |
chr17_+_37783453 | 1.25 |
ENST00000579000.1
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
chr7_+_86273952 | 1.25 |
ENST00000536043.1
|
GRM3
|
glutamate receptor, metabotropic 3 |
chr9_-_93405352 | 1.24 |
ENST00000375765.3
|
DIRAS2
|
DIRAS family, GTP-binding RAS-like 2 |
chr20_-_45280091 | 1.24 |
ENST00000396360.1
ENST00000435032.1 ENST00000413164.2 ENST00000372121.1 ENST00000339636.3 |
SLC13A3
|
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 |
chr1_+_156611960 | 1.24 |
ENST00000361588.5
|
BCAN
|
brevican |
chr18_+_32290218 | 1.22 |
ENST00000348997.5
ENST00000588949.1 ENST00000597599.1 |
DTNA
|
dystrobrevin, alpha |
chr17_-_39661849 | 1.22 |
ENST00000246635.3
ENST00000336861.3 ENST00000587544.1 ENST00000587435.1 |
KRT13
|
keratin 13 |
chr1_+_55107449 | 1.22 |
ENST00000421030.2
ENST00000545244.1 ENST00000339553.5 ENST00000409996.1 ENST00000454855.2 |
MROH7
|
maestro heat-like repeat family member 7 |
chr1_+_66999799 | 1.22 |
ENST00000371035.3
ENST00000371036.3 ENST00000371037.4 |
SGIP1
|
SH3-domain GRB2-like (endophilin) interacting protein 1 |
chr9_-_95298927 | 1.21 |
ENST00000395534.2
|
ECM2
|
extracellular matrix protein 2, female organ and adipocyte specific |
chr11_-_10920838 | 1.21 |
ENST00000503469.2
|
CTD-2003C8.2
|
CTD-2003C8.2 |
chr8_+_38965048 | 1.21 |
ENST00000399831.3
ENST00000437682.2 ENST00000519315.1 ENST00000379907.4 ENST00000522506.1 |
ADAM32
|
ADAM metallopeptidase domain 32 |
chrX_-_48216101 | 1.21 |
ENST00000298396.2
ENST00000376893.3 |
SSX3
|
synovial sarcoma, X breakpoint 3 |
chr5_-_54529415 | 1.20 |
ENST00000282572.4
|
CCNO
|
cyclin O |
chr3_-_149293990 | 1.20 |
ENST00000472417.1
|
WWTR1
|
WW domain containing transcription regulator 1 |
chr18_-_48346130 | 1.20 |
ENST00000592966.1
|
MRO
|
maestro |
chr13_-_62001982 | 1.20 |
ENST00000409186.1
|
PCDH20
|
protocadherin 20 |
chr21_-_22175450 | 1.20 |
ENST00000435279.2
|
LINC00320
|
long intergenic non-protein coding RNA 320 |
chr12_-_4758159 | 1.20 |
ENST00000545990.2
|
AKAP3
|
A kinase (PRKA) anchor protein 3 |
chr1_-_21948906 | 1.20 |
ENST00000374761.2
ENST00000599760.1 |
RAP1GAP
|
RAP1 GTPase activating protein |
chr3_-_47324060 | 1.20 |
ENST00000452770.2
|
KIF9
|
kinesin family member 9 |
chrX_-_102565858 | 1.19 |
ENST00000449185.1
ENST00000536889.1 |
BEX2
|
brain expressed X-linked 2 |
chr11_+_86106208 | 1.19 |
ENST00000528728.1
|
CCDC81
|
coiled-coil domain containing 81 |
chr17_-_55822653 | 1.19 |
ENST00000299415.2
|
AC007431.1
|
coiled-coil domain containing 182 |
chr12_-_23737534 | 1.18 |
ENST00000396007.2
|
SOX5
|
SRY (sex determining region Y)-box 5 |
chr3_-_10452359 | 1.18 |
ENST00000452124.1
|
ATP2B2
|
ATPase, Ca++ transporting, plasma membrane 2 |
chr21_-_22175341 | 1.18 |
ENST00000416768.1
ENST00000452561.1 ENST00000419299.1 ENST00000437238.1 |
LINC00320
|
long intergenic non-protein coding RNA 320 |
chr12_+_26126681 | 1.18 |
ENST00000542865.1
|
RASSF8
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 8 |
chr13_+_88325498 | 1.17 |
ENST00000400028.3
|
SLITRK5
|
SLIT and NTRK-like family, member 5 |
chr7_+_55177416 | 1.17 |
ENST00000450046.1
ENST00000454757.2 |
EGFR
|
epidermal growth factor receptor |
chr1_-_228353112 | 1.17 |
ENST00000366713.1
|
IBA57-AS1
|
IBA57 antisense RNA 1 (head to head) |
chr12_+_53443680 | 1.16 |
ENST00000314250.6
ENST00000451358.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr15_-_27184664 | 1.16 |
ENST00000541819.2
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
chr2_+_210444748 | 1.16 |
ENST00000392194.1
|
MAP2
|
microtubule-associated protein 2 |
chr7_+_23749945 | 1.16 |
ENST00000354639.3
ENST00000531170.1 ENST00000444333.2 ENST00000428484.1 |
STK31
|
serine/threonine kinase 31 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 4.6 | GO:0018963 | insecticide metabolic process(GO:0017143) phthalate metabolic process(GO:0018963) |
1.0 | 7.2 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
1.0 | 2.9 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
1.0 | 4.8 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
0.9 | 4.4 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.9 | 2.6 | GO:0018969 | thiocyanate metabolic process(GO:0018969) |
0.8 | 8.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.7 | 3.0 | GO:0009913 | epidermal cell differentiation(GO:0009913) keratinocyte differentiation(GO:0030216) |
0.7 | 2.1 | GO:0060304 | regulation of phosphatidylinositol dephosphorylation(GO:0060304) |
0.7 | 2.8 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.6 | 3.2 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.6 | 1.8 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
0.6 | 4.7 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.6 | 2.3 | GO:1901846 | positive regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901846) |
0.6 | 2.8 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.5 | 1.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.5 | 1.5 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.5 | 1.4 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.5 | 3.3 | GO:1903281 | protein transport into plasma membrane raft(GO:0044861) positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.4 | 2.2 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
0.4 | 1.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.4 | 3.5 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.4 | 5.5 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.4 | 0.8 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.4 | 3.3 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.4 | 1.2 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.4 | 1.2 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.4 | 1.5 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
0.4 | 1.1 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.3 | 1.0 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.3 | 2.1 | GO:0015744 | tricarboxylic acid transport(GO:0006842) succinate transport(GO:0015744) citrate transport(GO:0015746) succinate transmembrane transport(GO:0071422) |
0.3 | 3.1 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.3 | 1.4 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.3 | 1.0 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) negative regulation of calcium:sodium antiporter activity(GO:1903280) |
0.3 | 1.7 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.3 | 2.3 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.3 | 0.3 | GO:0007140 | male meiosis(GO:0007140) |
0.3 | 1.2 | GO:0018874 | benzoate metabolic process(GO:0018874) |
0.3 | 0.3 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.3 | 1.2 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.3 | 3.2 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.3 | 0.9 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
0.3 | 0.8 | GO:0040040 | thermosensory behavior(GO:0040040) |
0.3 | 1.4 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) |
0.3 | 1.1 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.3 | 1.1 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.3 | 1.4 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
0.3 | 2.7 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
0.3 | 0.8 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.3 | 1.6 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 4.8 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.3 | 1.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.3 | 0.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 1.0 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.3 | 6.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 4.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 1.0 | GO:0060254 | regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
0.3 | 3.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.3 | 1.0 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.2 | 1.2 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.2 | 1.7 | GO:0008218 | bioluminescence(GO:0008218) |
0.2 | 0.7 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
0.2 | 0.7 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
0.2 | 2.2 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.2 | 1.9 | GO:0019236 | response to pheromone(GO:0019236) |
0.2 | 1.2 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.2 | 0.9 | GO:0010652 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
0.2 | 5.7 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.2 | 0.7 | GO:2001037 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.2 | 0.7 | GO:0097178 | ruffle organization(GO:0031529) ruffle assembly(GO:0097178) |
0.2 | 0.7 | GO:0060129 | regulation of calcium-independent cell-cell adhesion(GO:0051040) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.2 | 0.9 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 0.9 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.2 | 3.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.2 | 0.7 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
0.2 | 0.9 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.2 | 2.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.8 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.2 | 0.6 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
0.2 | 0.4 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.2 | 1.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.2 | 1.8 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 0.2 | GO:1901090 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.2 | 1.2 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.2 | 1.2 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.2 | 3.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 1.3 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
0.2 | 1.3 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.2 | 1.1 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.2 | 1.7 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.2 | 1.3 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.2 | 0.7 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.2 | 1.3 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.2 | 0.9 | GO:0046108 | uridine metabolic process(GO:0046108) |
0.2 | 0.7 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.2 | 0.9 | GO:0060492 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.2 | 0.5 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.2 | 1.6 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 0.7 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.2 | 0.7 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.2 | 1.4 | GO:1902613 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
0.2 | 0.9 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 | 0.7 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 0.5 | GO:1902598 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
0.2 | 0.8 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.2 | 1.7 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.2 | 1.1 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.2 | 1.0 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.2 | 1.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 1.2 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.2 | 3.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.2 | 0.9 | GO:2000329 | negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
0.2 | 0.9 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 2.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.8 | GO:1901994 | meiotic DNA integrity checkpoint(GO:0044778) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.2 | 1.8 | GO:0097106 | postsynaptic density organization(GO:0097106) |
0.1 | 0.4 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.1 | 0.6 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 0.9 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 4.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.1 | 1.0 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.8 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 1.0 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.1 | 1.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.8 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 1.9 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.8 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.1 | 0.4 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.1 | 1.9 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.1 | 0.9 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.5 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.1 | 1.6 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 0.4 | GO:0019240 | protein citrullination(GO:0018101) peptidyl-arginine modification(GO:0018195) citrulline biosynthetic process(GO:0019240) histone citrullination(GO:0036414) |
0.1 | 1.4 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 1.5 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 1.9 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 1.0 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 1.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 7.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 1.0 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.4 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
0.1 | 0.5 | GO:0051710 | cytolysis by symbiont of host cells(GO:0001897) regulation of cytolysis in other organism(GO:0051710) cytolysis in other organism involved in symbiotic interaction(GO:0051801) |
0.1 | 1.7 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.7 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.9 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.1 | 0.4 | GO:0061566 | dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
0.1 | 0.7 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 0.4 | GO:0071469 | detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) cellular response to alkaline pH(GO:0071469) |
0.1 | 0.7 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.1 | 0.7 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
0.1 | 0.9 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 2.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 2.6 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.1 | 0.6 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 1.7 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.4 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.1 | 3.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.5 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 1.0 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 2.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.6 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
0.1 | 2.8 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 1.0 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.1 | 0.7 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 2.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 2.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.6 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.1 | 0.4 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 0.9 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 0.5 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.1 | 0.3 | GO:0050893 | sensory processing(GO:0050893) |
0.1 | 1.0 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.2 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.9 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
0.1 | 1.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 4.7 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.1 | 1.4 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.3 | GO:0060032 | notochord regression(GO:0060032) |
0.1 | 0.4 | GO:0036269 | swimming behavior(GO:0036269) |
0.1 | 0.5 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
0.1 | 0.6 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.1 | 1.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 1.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.4 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 3.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.8 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 2.0 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.1 | 0.4 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.1 | 1.4 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 3.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.3 | GO:1901536 | negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.9 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.3 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.1 | 3.5 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.1 | 0.3 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.1 | 1.9 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.3 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.1 | 1.0 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.1 | 0.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.7 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.9 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 1.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 1.4 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 1.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.7 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
0.1 | 0.8 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.7 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.5 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.1 | 0.8 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 2.6 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.4 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 1.5 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.1 | 0.4 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.8 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.1 | 1.1 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.9 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.1 | 0.4 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.1 | 0.5 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.1 | 0.1 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.1 | 0.8 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.6 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.3 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.3 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 0.4 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.3 | GO:2000314 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.1 | 1.5 | GO:0060390 | negative regulation of catenin import into nucleus(GO:0035414) regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 1.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.3 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 1.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.3 | GO:0015811 | L-cystine transport(GO:0015811) |
0.1 | 0.3 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.1 | 0.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.6 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.1 | 4.0 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.4 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 0.5 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.6 | GO:0042048 | olfactory behavior(GO:0042048) |
0.1 | 0.3 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
0.1 | 2.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.4 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.1 | 0.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.5 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.8 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 2.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.5 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 1.1 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.1 | 0.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.4 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.1 | 0.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 2.0 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.4 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.6 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 1.3 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.1 | 0.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.5 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.1 | 0.7 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.2 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.8 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.9 | GO:0007625 | grooming behavior(GO:0007625) |
0.1 | 0.6 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.7 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.5 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 1.8 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.1 | 0.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 1.0 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.0 | 0.9 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.2 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.0 | 0.4 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 1.6 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.0 | 0.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.3 | GO:0051012 | microtubule sliding(GO:0051012) |
0.0 | 1.7 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 1.9 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.0 | 0.3 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.0 | 1.2 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.2 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.0 | 0.7 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.4 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.9 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.0 | 0.7 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 3.6 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 2.7 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.0 | 0.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.2 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.0 | 0.2 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.0 | 0.8 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.0 | 0.3 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.7 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 7.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.4 | GO:0070836 | caveola assembly(GO:0070836) |
0.0 | 0.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.6 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.0 | 0.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.2 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.0 | 0.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.2 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.0 | 1.2 | GO:0030325 | adrenal gland development(GO:0030325) |
0.0 | 0.2 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) |
0.0 | 0.4 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.0 | 0.4 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 1.4 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.5 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.0 | 0.2 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.0 | 0.1 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.0 | 0.6 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.0 | 0.4 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 1.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.5 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.5 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 1.0 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.8 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.0 | 0.1 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.0 | 0.4 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.0 | 0.4 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.4 | GO:0021795 | cerebral cortex cell migration(GO:0021795) |
0.0 | 0.5 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.1 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.0 | 0.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.2 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.1 | GO:0060027 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) convergent extension involved in gastrulation(GO:0060027) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.3 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.0 | 0.2 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.0 | 0.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.2 | GO:0030073 | insulin secretion(GO:0030073) |
0.0 | 0.6 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.0 | 0.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 1.1 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
0.0 | 0.1 | GO:0035803 | egg coat formation(GO:0035803) |
0.0 | 0.2 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
0.0 | 1.0 | GO:0098655 | cation transmembrane transport(GO:0098655) |
0.0 | 0.6 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.0 | 0.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.9 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.0 | 0.1 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
0.0 | 0.0 | GO:0003352 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.6 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
0.0 | 0.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.8 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 1.0 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.3 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.0 | 0.5 | GO:0000717 | nucleotide-excision repair, DNA duplex unwinding(GO:0000717) |
0.0 | 0.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.9 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 17.7 | GO:0007283 | spermatogenesis(GO:0007283) |
0.0 | 0.2 | GO:0000819 | mitotic sister chromatid segregation(GO:0000070) sister chromatid segregation(GO:0000819) |
0.0 | 0.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.5 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.0 | 0.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.1 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
0.0 | 4.0 | GO:0008584 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.0 | 1.7 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 0.8 | GO:0048665 | neuron fate specification(GO:0048665) |
0.0 | 0.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.1 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.0 | 0.1 | GO:0030185 | nitric oxide transport(GO:0030185) |
0.0 | 0.3 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.0 | 0.4 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.2 | GO:0021902 | forebrain neuron fate commitment(GO:0021877) commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 0.1 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.0 | 0.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 1.5 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 1.5 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.0 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.0 | 2.4 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.0 | 0.5 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 1.4 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 0.1 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.0 | 0.2 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.0 | 0.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.7 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 0.2 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.0 | 0.1 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) RNA repair(GO:0042245) |
0.0 | 0.7 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.1 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.0 | 0.1 | GO:0070781 | response to biotin(GO:0070781) |
0.0 | 0.4 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.7 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.1 | GO:0030070 | insulin processing(GO:0030070) |
0.0 | 0.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 1.7 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.7 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.3 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.0 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.0 | 0.0 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.6 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.0 | 5.5 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 1.2 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.8 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.2 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 1.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.4 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.1 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.0 | 0.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.0 | 0.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.0 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.0 | 1.1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.5 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.9 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.0 | 2.1 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.8 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 0.2 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.3 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.0 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.0 | 0.2 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.5 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.1 |